Helix BioPharma Corp. Net Asset Quality Index
Helix BioPharma Corp. net asset quality index. Helix BioPharma Corp. (HBP) has a Net Asset Quality Index of 82.9% as of January 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CA$18.52 Million minus total liabilities of CA$3.16 Million yields net assets of CA$15.36 Million. A higher index indicates a stronger, lower-leverage balance sheet. See HBP net asset value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Helix BioPharma Corp. (2007–2025)
Net asset quality index of Helix BioPharma Corp. from 2007 to 2025. This chart shows how Helix BioPharma Corp.'s Net Asset Quality Index has evolved across 19 annual periods from 2007 to 2025. As of January 2026, the index stands at 82.9%, representing net assets of CA$15.36 Million against total assets of CA$18.52 Million CAD. Check asset allocation strategy of Helix BioPharma Corp. to assess the company's strategic physical and investment asset allocation.
Helix BioPharma Corp. Net Asset Quality Index by Year (2007–2025)
Helix BioPharma Corp. net asset quality index by year from 2007 to 2025. The table below presents the year-by-year Net Asset Quality Index for Helix BioPharma Corp. from 2007 to 2025, covering 19 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Helix BioPharma Corp..
| Year | Quality Index | Net Assets (CAD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 82.9% | CA$15.59 Million | CA$18.80 Million | CA$3.22 Million | ▲ +88.9 pp |
| 2024 | -6.0% | CA$-90.00K | CA$1.49 Million | CA$1.58 Million | ▲ +76.0 pp |
| 2023 | -82.0% | CA$-844.00K | CA$1.03 Million | CA$1.87 Million | ▼ -90.6 pp |
| 2022 | 8.6% | CA$319.00K | CA$3.73 Million | CA$3.41 Million | ▲ +42.8 pp |
| 2021 | -34.3% | CA$-1.39 Million | CA$4.07 Million | CA$5.46 Million | ▼ -95.0 pp |
| 2020 | 60.8% | CA$2.98 Million | CA$4.91 Million | CA$1.93 Million | ▲ +409.8 pp |
| 2019 | -349.0% | CA$-3.28 Million | CA$940.00K | CA$4.22 Million | ▼ -215.9 pp |
| 2018 | -133.1% | CA$-1.53 Million | CA$1.15 Million | CA$2.67 Million | ▼ -132.4 pp |
| 2017 | -0.8% | CA$-17.00K | CA$2.19 Million | CA$2.20 Million | ▼ -71.6 pp |
| 2016 | 70.8% | CA$3.16 Million | CA$4.47 Million | CA$1.30 Million | ▼ -16.8 pp |
| 2015 | 87.6% | CA$6.83 Million | CA$7.80 Million | CA$969.00K | ▲ +0.8 pp |
| 2014 | 86.7% | CA$6.81 Million | CA$7.85 Million | CA$1.04 Million | ▲ +2.9 pp |
| 2013 | 83.8% | CA$4.92 Million | CA$5.87 Million | CA$948.00K | ▲ +2.1 pp |
| 2012 | 81.7% | CA$6.22 Million | CA$7.62 Million | CA$1.39 Million | ▼ -9.0 pp |
| 2011 | 90.7% | CA$22.11 Million | CA$24.37 Million | CA$2.26 Million | ▲ +3.7 pp |
| 2010 | 87.0% | CA$15.76 Million | CA$18.11 Million | CA$2.35 Million | ▼ -1.3 pp |
| 2009 | 88.3% | CA$17.06 Million | CA$19.32 Million | CA$2.26 Million | ▼ -6.4 pp |
| 2008 | 94.7% | CA$20.52 Million | CA$21.67 Million | CA$1.14 Million | ▲ +5.5 pp |
| 2007 | 89.2% | CA$12.73 Million | CA$14.27 Million | CA$1.54 Million | — |